Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Thursday, Abbott Laboratories (NYSE:ABT) said it is recalling some FreeStyle Libre 3 sensors after finding ... Continuous ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

All cloud-to-cloud connections for Tidepool are designed with simplicity and streamlined workflows in mind. Clinics and ...

We recently published a list of 10 Best Medical Stocks to Buy Now. In this article, we are going to take a look at where ...

Clinics and health systems using Tidepool+ will be able to initiate the connection with their patients using FreeStyle Libre 2 and 3 systems in clinic or remotely. Tidepool+ will seamlessly merge ...

Adjusted SG&A Expense: 27.2% of sales ... 1.6 billion in sales. Abbott Laboratories (NYSE:ABT) entered into a global partnership with Medtronic to connect its FreeStyle Libre CGM sensor with ...